Earnings Call · Q1 FY2021·2021-05-17

Q1 21EPS -15.49%·Rev n/aQ4 20EPS -2.86%·Rev n/aQ3 20EPS +10.53%·Rev n/aQ2 20EPS +10.59%·Rev n/a⚠ consensus missing

Cue Biopharma, Inc. CUE

George Zavoico — Investor Relations or Communications (inferred from role introducing executives)

Daniel Passeri — Chief Executive Officer

Anish Suri — President and Chief Scientific Officer

Ken Pienta — Acting Chief Medical Officer

Matteo Levisetti — Senior Vice President of Clinical Development

Kerri-Ann Millar — Senior Vice President of Finance and Chief Financial Officer

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CUE calls or request research access.

More CUE calls Browse calls Request research access